世界の特殊有効成分市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Specialty Active Pharmaceutical Ingredients Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-105X19421 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、特殊有効成分のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。特殊有効成分の種類別市場規模（ステロイドAPI、ペプチドAPI、炭水化物API、小分子API、高力価AP）、用途別市場規模（CNS、心臓血管、泌尿生殖器/ホルモン薬、リウマチ学、糖尿病、腫瘍、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・特殊有効成分の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Sanofi、Cambrex、Almac、Johnson Matthey、PolyPeptide、AmbioPharm、Avecia、ST Pharm、Biospring ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ステロイドAPI、ペプチドAPI、炭水化物API、小分子API、高力価AP ・用途別分析2016年-2026年：CNS、心臓血管、泌尿生殖器/ホルモン薬、リウマチ学、糖尿病、腫瘍、その他 ・特殊有効成分の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・特殊有効成分のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・特殊有効成分のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・特殊有効成分の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・特殊有効成分の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Specialty Active Pharmaceutical Ingredients market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Specialty Active Pharmaceutical Ingredients size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Specialty Active Pharmaceutical Ingredients market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Specialty Active Pharmaceutical Ingredients market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Steroidal API
Peptide API
Carbohydrate API
Small Molecule API
High Potency AP

Market segment by Application can be divided into
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Rheumatology
Diabetes
Oncology
Others

The key market players for global Specialty Active Pharmaceutical Ingredients market are listed below:
Sanofi
Cambrex
Almac
Johnson Matthey
PolyPeptide
AmbioPharm
Avecia
ST Pharm
Biospring

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Specialty Active Pharmaceutical Ingredients Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Specialty Active Pharmaceutical Ingredients Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Steroidal API
1.2.3 Peptide API
1.2.4 Carbohydrate API
1.2.5 Small Molecule API
1.2.6 High Potency AP
1.3 Market Analysis by Application
1.3.1 Overview: Global Specialty Active Pharmaceutical Ingredients Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Genitourinary/Hormonal Drugs
1.3.5 Rheumatology
1.3.6 Diabetes
1.3.7 Oncology
1.3.8 Others
1.4 Global Specialty Active Pharmaceutical Ingredients Market Size & Forecast
1.4.1 Global Specialty Active Pharmaceutical Ingredients Sales in Value (2016-2026))
1.4.2 Global Specialty Active Pharmaceutical Ingredients Sales in Volume (2016-2026)
1.4.3 Global Specialty Active Pharmaceutical Ingredients Price by Type (2016-2026) & (USD/MT)
1.5 Global Specialty Active Pharmaceutical Ingredients Production Capacity Analysis
1.5.1 Global Specialty Active Pharmaceutical Ingredients Total Production Capacity (2016-2026)
1.5.2 Global Specialty Active Pharmaceutical Ingredients Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Specialty Active Pharmaceutical Ingredients Market Drivers
1.6.2 Specialty Active Pharmaceutical Ingredients Market Restraints
1.6.3 Specialty Active Pharmaceutical Ingredients Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Specialty Active Pharmaceutical Ingredients Product and Services
2.1.4 Sanofi Specialty Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Cambrex
2.2.1 Cambrex Details
2.2.2 Cambrex Major Business
2.2.3 Cambrex Specialty Active Pharmaceutical Ingredients Product and Services
2.2.4 Cambrex Specialty Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Almac
2.3.1 Almac Details
2.3.2 Almac Major Business
2.3.3 Almac Specialty Active Pharmaceutical Ingredients Product and Services
2.3.4 Almac Specialty Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Johnson Matthey
2.4.1 Johnson Matthey Details
2.4.2 Johnson Matthey Major Business
2.4.3 Johnson Matthey Specialty Active Pharmaceutical Ingredients Product and Services
2.4.4 Johnson Matthey Specialty Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 PolyPeptide
2.5.1 PolyPeptide Details
2.5.2 PolyPeptide Major Business
2.5.3 PolyPeptide Specialty Active Pharmaceutical Ingredients Product and Services
2.5.4 PolyPeptide Specialty Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 AmbioPharm
2.6.1 AmbioPharm Details
2.6.2 AmbioPharm Major Business
2.6.3 AmbioPharm Specialty Active Pharmaceutical Ingredients Product and Services
2.6.4 AmbioPharm Specialty Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Avecia
2.7.1 Avecia Details
2.7.2 Avecia Major Business
2.7.3 Avecia Specialty Active Pharmaceutical Ingredients Product and Services
2.7.4 Avecia Specialty Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 ST Pharm
2.8.1 ST Pharm Details
2.8.2 ST Pharm Major Business
2.8.3 ST Pharm Specialty Active Pharmaceutical Ingredients Product and Services
2.8.4 ST Pharm Specialty Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Biospring
2.9.1 Biospring Details
2.9.2 Biospring Major Business
2.9.3 Biospring Specialty Active Pharmaceutical Ingredients Product and Services
2.9.4 Biospring Specialty Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Specialty Active Pharmaceutical Ingredients Sales by Manufacturer
3.1 Global Specialty Active Pharmaceutical Ingredients Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Specialty Active Pharmaceutical Ingredients Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Specialty Active Pharmaceutical Ingredients
3.4 Market Concentration Rate
3.4.1 Top 3 Specialty Active Pharmaceutical Ingredients Manufacturer Market Share
3.4.2 Top 6 Specialty Active Pharmaceutical Ingredients Manufacturer Market Share
3.5 Global Specialty Active Pharmaceutical Ingredients Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Specialty Active Pharmaceutical Ingredients Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Specialty Active Pharmaceutical Ingredients Market Size by Region
4.1.1 Global Specialty Active Pharmaceutical Ingredients Sales in Volume by Region (2016-2026)
4.1.2 Global Specialty Active Pharmaceutical Ingredients Revenue by Region (2016-2026)
4.2 North America Specialty Active Pharmaceutical Ingredients Revenue (2016-2026)
4.3 Europe Specialty Active Pharmaceutical Ingredients Revenue (2016-2026)
4.4 Asia-Pacific Specialty Active Pharmaceutical Ingredients Revenue (2016-2026)
4.5 South America Specialty Active Pharmaceutical Ingredients Revenue (2016-2026)
4.6 Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Specialty Active Pharmaceutical Ingredients Sales in Volume by Type (2016-2026)
5.2 Global Specialty Active Pharmaceutical Ingredients Revenue by Type (2016-2026)
5.3 Global Specialty Active Pharmaceutical Ingredients Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Specialty Active Pharmaceutical Ingredients Sales in Volume by Application (2016-2026)
6.2 Global Specialty Active Pharmaceutical Ingredients Revenue by Application (2016-2026)
6.3 Global Specialty Active Pharmaceutical Ingredients Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Specialty Active Pharmaceutical Ingredients Sales by Type (2016-2026)
7.2 North America Specialty Active Pharmaceutical Ingredients Sales by Application (2016-2026)
7.3 North America Specialty Active Pharmaceutical Ingredients Market Size by Country
7.3.1 North America Specialty Active Pharmaceutical Ingredients Sales in Volume by Country (2016-2026)
7.3.2 North America Specialty Active Pharmaceutical Ingredients Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Specialty Active Pharmaceutical Ingredients Sales by Type (2016-2026)
8.2 Europe Specialty Active Pharmaceutical Ingredients Sales by Application (2016-2026)
8.3 Europe Specialty Active Pharmaceutical Ingredients Market Size by Country
8.3.1 Europe Specialty Active Pharmaceutical Ingredients Sales in Volume by Country (2016-2026)
8.3.2 Europe Specialty Active Pharmaceutical Ingredients Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Specialty Active Pharmaceutical Ingredients Sales by Type (2016-2026)
9.2 Asia-Pacific Specialty Active Pharmaceutical Ingredients Sales by Application (2016-2026)
9.3 Asia-Pacific Specialty Active Pharmaceutical Ingredients Market Size by Region
9.3.1 Asia-Pacific Specialty Active Pharmaceutical Ingredients Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Specialty Active Pharmaceutical Ingredients Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Specialty Active Pharmaceutical Ingredients Sales by Type (2016-2026)
10.2 South America Specialty Active Pharmaceutical Ingredients Sales by Application (2016-2026)
10.3 South America Specialty Active Pharmaceutical Ingredients Market Size by Country
10.3.1 South America Specialty Active Pharmaceutical Ingredients Sales in Volume by Country (2016-2026)
10.3.2 South America Specialty Active Pharmaceutical Ingredients Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Specialty Active Pharmaceutical Ingredients Sales by Type (2016-2026)
11.2 Middle East & Africa Specialty Active Pharmaceutical Ingredients Sales by Application (2016-2026)
11.3 Middle East & Africa Specialty Active Pharmaceutical Ingredients Market Size by Country
11.3.1 Middle East & Africa Specialty Active Pharmaceutical Ingredients Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Specialty Active Pharmaceutical Ingredients Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Specialty Active Pharmaceutical Ingredients Typical Distributors
12.3 Specialty Active Pharmaceutical Ingredients Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Specialty Active Pharmaceutical Ingredients Revenue by Type, (USD Million), 2021-2026
Table 2. Global Specialty Active Pharmaceutical Ingredients Revenue by Application, (USD Million), 2021-2026
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Specialty Active Pharmaceutical Ingredients Product and Services
Table 6. Sanofi Specialty Active Pharmaceutical Ingredients Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Cambrex Basic Information, Manufacturing Base and Competitors
Table 8. Cambrex Major Business
Table 9. Cambrex Specialty Active Pharmaceutical Ingredients Product and Services
Table 10. Cambrex Specialty Active Pharmaceutical Ingredients Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Almac Basic Information, Manufacturing Base and Competitors
Table 12. Almac Major Business
Table 13. Almac Specialty Active Pharmaceutical Ingredients Product and Services
Table 14. Almac Specialty Active Pharmaceutical Ingredients Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Johnson Matthey Basic Information, Manufacturing Base and Competitors
Table 16. Johnson Matthey Major Business
Table 17. Johnson Matthey Specialty Active Pharmaceutical Ingredients Product and Services
Table 18. Johnson Matthey Specialty Active Pharmaceutical Ingredients Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. PolyPeptide Basic Information, Manufacturing Base and Competitors
Table 20. PolyPeptide Major Business
Table 21. PolyPeptide Specialty Active Pharmaceutical Ingredients Product and Services
Table 22. PolyPeptide Specialty Active Pharmaceutical Ingredients Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. AmbioPharm Basic Information, Manufacturing Base and Competitors
Table 24. AmbioPharm Major Business
Table 25. AmbioPharm Specialty Active Pharmaceutical Ingredients Product and Services
Table 26. AmbioPharm Specialty Active Pharmaceutical Ingredients Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Avecia Basic Information, Manufacturing Base and Competitors
Table 28. Avecia Major Business
Table 29. Avecia Specialty Active Pharmaceutical Ingredients Product and Services
Table 30. Avecia Specialty Active Pharmaceutical Ingredients Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. ST Pharm Basic Information, Manufacturing Base and Competitors
Table 32. ST Pharm Major Business
Table 33. ST Pharm Specialty Active Pharmaceutical Ingredients Product and Services
Table 34. ST Pharm Specialty Active Pharmaceutical Ingredients Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Biospring Basic Information, Manufacturing Base and Competitors
Table 36. Biospring Major Business
Table 37. Biospring Specialty Active Pharmaceutical Ingredients Product and Services
Table 38. Biospring Specialty Active Pharmaceutical Ingredients Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Specialty Active Pharmaceutical Ingredients Sales by Manufacturer (2019-2021e) & (K MT)
Table 40. Global Specialty Active Pharmaceutical Ingredients Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Specialty Active Pharmaceutical Ingredients, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Specialty Active Pharmaceutical Ingredients Production Capacity by Company, (K MT): 2020 VS 2021
Table 43. Head Office and Specialty Active Pharmaceutical Ingredients Production Site of Key Manufacturer
Table 44. Global Specialty Active Pharmaceutical Ingredients Sales by Region (2016-2021e) & (K MT)
Table 45. Global Specialty Active Pharmaceutical Ingredients Sales by Region (2021-2026) & (K MT)
Table 46. Global Specialty Active Pharmaceutical Ingredients Revenue by Region (2016-2021e) & (USD Million)
Table 47. Global Specialty Active Pharmaceutical Ingredients Revenue by Region (2021-2026) & (USD Million)
Table 48. Global Specialty Active Pharmaceutical Ingredients Sales by Type (2016-2021e) & (K MT)
Table 49. Global Specialty Active Pharmaceutical Ingredients Sales by Type (2021-2026) & (K MT)
Table 50. Global Specialty Active Pharmaceutical Ingredients Revenue by Type (2016-2021e) & (USD Million)
Table 51. Global Specialty Active Pharmaceutical Ingredients Revenue by Type (2021-2026) & (USD Million)
Table 52. Global Specialty Active Pharmaceutical Ingredients Price by Type (2016-2021e) & (USD/MT)
Table 53. Global Specialty Active Pharmaceutical Ingredients Price by Type (2021-2026) & (USD/MT)
Table 54. Global Specialty Active Pharmaceutical Ingredients Sales by Application (2016-2021e) & (K MT)
Table 55. Global Specialty Active Pharmaceutical Ingredients Sales by Application (2021-2026) & (K MT)
Table 56. Global Specialty Active Pharmaceutical Ingredients Revenue by Application (2016-2021e) & (USD Million)
Table 57. Global Specialty Active Pharmaceutical Ingredients Revenue by Application (2021-2026) & (USD Million)
Table 58. Global Specialty Active Pharmaceutical Ingredients Price by Application (2016-2021e) & (USD/MT)
Table 59. Global Specialty Active Pharmaceutical Ingredients Price by Application (2021-2026) & (USD/MT)
Table 60. North America Specialty Active Pharmaceutical Ingredients Sales by Country (2016-2021e) & (K MT)
Table 61. North America Specialty Active Pharmaceutical Ingredients Sales by Country (2021-2026) & (K MT)
Table 62. North America Specialty Active Pharmaceutical Ingredients Revenue by Country (2016-2021e) & (USD Million)
Table 63. North America Specialty Active Pharmaceutical Ingredients Revenue by Country (2021-2026) & (USD Million)
Table 64. North America Specialty Active Pharmaceutical Ingredients Sales by Type (2016-2021e) & (K MT)
Table 65. North America Specialty Active Pharmaceutical Ingredients Sales by Type (2021-2026) & (K MT)
Table 66. North America Specialty Active Pharmaceutical Ingredients Sales by Application (2016-2021e) & (K MT)
Table 67. North America Specialty Active Pharmaceutical Ingredients Sales by Application (2021-2026) & (K MT)
Table 68. Europe Specialty Active Pharmaceutical Ingredients Sales by Country (2016-2021e) & (K MT)
Table 69. Europe Specialty Active Pharmaceutical Ingredients Sales by Country (2021-2026) & (K MT)
Table 70. Europe Specialty Active Pharmaceutical Ingredients Revenue by Country (2016-2021e) & (USD Million)
Table 71. Europe Specialty Active Pharmaceutical Ingredients Revenue by Country (2021-2026) & (USD Million)
Table 72. Europe Specialty Active Pharmaceutical Ingredients Sales by Type (2016-2021e) & (K MT)
Table 73. Europe Specialty Active Pharmaceutical Ingredients Sales by Type (2021-2026) & (K MT)
Table 74. Europe Specialty Active Pharmaceutical Ingredients Sales by Application (2016-2021e) & (K MT)
Table 75. Europe Specialty Active Pharmaceutical Ingredients Sales by Application (2021-2026) & (K MT)
Table 76. Asia-Pacific Specialty Active Pharmaceutical Ingredients Sales by Region (2016-2021e) & (K MT)
Table 77. Asia-Pacific Specialty Active Pharmaceutical Ingredients Sales by Region (2021-2026) & (K MT)
Table 78. Asia-Pacific Specialty Active Pharmaceutical Ingredients Revenue by Region (2016-2021e) & (USD Million)
Table 79. Asia-Pacific Specialty Active Pharmaceutical Ingredients Revenue by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Specialty Active Pharmaceutical Ingredients Sales by Type (2016-2021e) & (K MT)
Table 81. Asia-Pacific Specialty Active Pharmaceutical Ingredients Sales by Type (2021-2026) & (K MT)
Table 82. Asia-Pacific Specialty Active Pharmaceutical Ingredients Sales by Application (2016-2021e) & (K MT)
Table 83. Asia-Pacific Specialty Active Pharmaceutical Ingredients Sales by Application (2021-2026) & (K MT)
Table 84. South America Specialty Active Pharmaceutical Ingredients Sales by Country (2016-2021e) & (K MT)
Table 85. South America Specialty Active Pharmaceutical Ingredients Sales by Country (2021-2026) & (K MT)
Table 86. South America Specialty Active Pharmaceutical Ingredients Revenue by Country (2016-2021e) & (USD Million)
Table 87. South America Specialty Active Pharmaceutical Ingredients Revenue by Country (2021-2026) & (USD Million)
Table 88. South America Specialty Active Pharmaceutical Ingredients Sales by Type (2016-2021e) & (K MT)
Table 89. South America Specialty Active Pharmaceutical Ingredients Sales by Type (2021-2026) & (K MT)
Table 90. South America Specialty Active Pharmaceutical Ingredients Sales by Application (2016-2021e) & (K MT)
Table 91. South America Specialty Active Pharmaceutical Ingredients Sales by Application (2021-2026) & (K MT)
Table 92. Middle East & Africa Specialty Active Pharmaceutical Ingredients Sales by Country (2016-2021e) & (K MT)
Table 93. Middle East & Africa Specialty Active Pharmaceutical Ingredients Sales by Country (2021-2026) & (K MT)
Table 94. Middle East & Africa Specialty Active Pharmaceutical Ingredients Revenue by Country (2016-2021e) & (USD Million)
Table 95. Middle East & Africa Specialty Active Pharmaceutical Ingredients Revenue by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Specialty Active Pharmaceutical Ingredients Sales by Type (2016-2021e) & (K MT)
Table 97. Middle East & Africa Specialty Active Pharmaceutical Ingredients Sales by Type (2021-2026) & (K MT)
Table 98. Middle East & Africa Specialty Active Pharmaceutical Ingredients Sales by Application (2016-2021e) & (K MT)
Table 99. Middle East & Africa Specialty Active Pharmaceutical Ingredients Sales by Application (2021-2026) & (K MT)
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Specialty Active Pharmaceutical Ingredients Typical Distributors
Table 103. Specialty Active Pharmaceutical Ingredients Typical Customers
List of Figures
Figure 1. Specialty Active Pharmaceutical Ingredients Picture
Figure 2. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Type in 2020
Figure 3. Steroidal API
Figure 4. Peptide API
Figure 5. Carbohydrate API
Figure 6. Small Molecule API
Figure 7. High Potency AP
Figure 8. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Application in 2020
Figure 9. CNS
Figure 10. Cardiovascular
Figure 11. Genitourinary/Hormonal Drugs
Figure 12. Rheumatology
Figure 13. Diabetes
Figure 14. Oncology
Figure 15. Others
Figure 16. Global Specialty Active Pharmaceutical Ingredients Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 17. Global Specialty Active Pharmaceutical Ingredients Market Size and Forecast (2016-2026) & (USD Million)
Figure 18. United States Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Canada Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Mexico Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Germany Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. France Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. United Kingdom Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Russia Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Italy Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. China Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Japan Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Korea Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. India Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Southeast Asia Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Australia Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Brazil Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Egypt Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Saudi Arabia Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. South Africa Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. Turkey Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 37. Global Specialty Active Pharmaceutical Ingredients Sales (2016-2026) & (K MT)
Figure 38. Global Specialty Active Pharmaceutical Ingredients Production Capacity (2016-2026) & (K MT)
Figure 39. Global Specialty Active Pharmaceutical Ingredients Production Capacity by Geographic Region: 2020 VS 2021
Figure 40. Specialty Active Pharmaceutical Ingredients Market Drivers
Figure 41. Specialty Active Pharmaceutical Ingredients Market Restraints
Figure 42. Specialty Active Pharmaceutical Ingredients Market Trends
Figure 43. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Manufacturer in 2020
Figure 44. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Manufacturer in 2020
Figure 45. Specialty Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 46. Top 3 Specialty Active Pharmaceutical Ingredients Manufacturer (Revenue) Market Share in 2020
Figure 47. Top 6 Specialty Active Pharmaceutical Ingredients Manufacturer (Revenue) Market Share in 2020
Figure 48. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2016-2026)
Figure 49. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region (2016-2026)
Figure 50. North America Specialty Active Pharmaceutical Ingredients Revenue (2016-2026) & (USD Million)
Figure 51. Europe Specialty Active Pharmaceutical Ingredients Revenue (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Specialty Active Pharmaceutical Ingredients Revenue (2016-2026) & (USD Million)
Figure 53. South America Specialty Active Pharmaceutical Ingredients Revenue (2016-2026) & (USD Million)
Figure 54. Middle East & Africa Specialty Active Pharmaceutical Ingredients Revenue (2016-2026) & (USD Million)
Figure 55. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2026)
Figure 56. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Type (2016-2026)
Figure 57. Global Specialty Active Pharmaceutical Ingredients Price by Type (2016-2026) & (USD/MT)
Figure 58. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2026)
Figure 59. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Application (2016-2026)
Figure 60. Global Specialty Active Pharmaceutical Ingredients Price by Application (2016-2026) & (USD/MT)
Figure 61. North America Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2026)
Figure 62. North America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2026)
Figure 63. North America Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2026)
Figure 64. North America Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2026)
Figure 65. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2026)
Figure 66. Europe Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2026)
Figure 67. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2026)
Figure 68. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2026)
Figure 69. Asia-Pacific Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region (2016-2026)
Figure 71. Asia-Pacific Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2016-2026)
Figure 72. Asia-Pacific Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2026)
Figure 73. South America Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2026)
Figure 74. South America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2026)
Figure 75. South America Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2026)
Figure 76. South America Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2026)
Figure 77. Middle East & Africa Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2026)
Figure 78. Middle East & Africa Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2026)
Figure 79. Middle East & Africa Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2026)
Figure 80. Middle East & Africa Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2026)
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source

---